PRAME and melanoma: The absence of established molecular drivers associated with melanoma such as BRAF V600E mutations, along with the lack of PRAME staining expression by immunohistochemistry, a marker that is often positive in melanoma, can help confirm a benign diagnosis in NCH [18,28,30].